Femoral osteofibrous dysplasia is a benign verrucous disease in which femoral bone fibrous tissue abnormally proliferates, degenerates, and chemotaxis into newborn intertwined bone. Femoral osteofibrous dysplasia, also known as femoral osteofibrous dysplasia, is a benign neoplastic disease in which abnormal bone development or endocrine abnormalities lead to abnormal proliferation, degeneration, and metaplasia of bone fiber tissue into a newborn intertwined bone. The disease is prevalent in young people aged 10 to 30 years old. Osteofibrous dysplasia of the femur mainly manifests as lesions of the femoral head, resulting in deformity of the femoral head, joint pain, and limitation of limb movement, and may also be manifested by skin pigmentation. For symptomatic femoral osteofibrous dysplasia, it is mainly treated by surgery, and the prognosis is generally better, and the rate of malignant changes is relatively low. It should be reminded that for patients with femoral osteofibrous dysplasia, early treatment is necessary to prevent the condition from worsening.